Perrone-Congedi (2021) multicenter LArge retrospectIve daTabase on the personalization of Stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: the laIT-SABR study. Radiother Oncol 166:92-99. https://doi.org/10.1016/j.radonc.2021.10.023 13. Bezjak A, Paulus R, Gaspar LE et al (2016) Primary study endpoint analysis for NRG oncology/RTOG 0813 trial of Stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 94(1):5-6 14. Whybra P, Parkinson C, Foley K et al (2019) Assessing radiomic feature robustness to interpolation in (18) F-FDG PET imaging. Sci Rep 9(1):9649 15. Zwanenburg A, Valli & egrave;res M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2):328-338. https://doi.org/10.1148/radiol.2020191145 16. Zwanenburg A, Leger S, Valli & egrave;res M et al (2016) Initiative, for the I. B. S. Image biomarker standardisation initiative (arXiv) 17. Tixier F, Hatt M, Le Rest CC et al (2012) Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53:693-700 j.radonc.2020.07.003 28. Tang C, Hobbs B, Amer pathology informed radiomics cer. Sci Rep 8(1):1922. 5 29. Lee K, Le T, Hau E et ological features predicting tive body radiotherapy cancer (NSCLC). Int J 1016/j.ijrobp.2021.11.027 30. Osti MF, Agolli L, Valeriani stereotactic body radiation a large series of patients Treat Res 122:165-170. 31. Helou J, Thibault I, Poon ation therapy for pulmonary cation matter. Int J Radiat doi.org/10.1016/j.ijrobp.2017.02.093 32. Virbel G, Le F & egrave;vre C, radiotherapy for patients year review. Cancers. https://doi.org/10.3390/cancers13143623